Association of proton pump inhibitor use with survival outcomes in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.

Chen B, Yang C, Dragomir MP, Chi D, Chen W, Horst D, Calin GA, Li Q

Open source

DOI
10.1177/17588359221111703
Published
2022
Container
Therapeutic advances in medical oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/17588359221111703,
  title = {Association of proton pump inhibitor use with survival outcomes in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.},
  author = {Chen B and Yang C and Dragomir MP and Chi D and Chen W and Horst D and Calin GA and Li Q},
  year = {2022},
  journal = {Therapeutic advances in medical oncology},
  doi = {10.1177/17588359221111703},
  url = {https://doi.org/10.1177/17588359221111703}
}

RIS

TY  - JOUR
TI  - Association of proton pump inhibitor use with survival outcomes in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
AU  - Chen B
AU  - Yang C
AU  - Dragomir MP
AU  - Chi D
AU  - Chen W
AU  - Horst D
AU  - Calin GA
AU  - Li Q
PY  - 2022
JO  - Therapeutic advances in medical oncology
DO  - 10.1177/17588359221111703
UR  - https://doi.org/10.1177/17588359221111703
ER  - 

APA

B, C., C, Y., MP, D., D, C., W, C., D, H., GA, C., & Q, L. (2022). Association of proton pump inhibitor use with survival outcomes in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.. Therapeutic advances in medical oncology. https://doi.org/10.1177/17588359221111703

Source records